Brewer Jerry D, Colegio Oscar R, Phillips P Kim, Roenigk Randall K, Jacobs M Amanda, Van de Beek Diederik, Dierkhising Ross A, Kremers Walter K, McGregor Christopher G A, Otley Clark C
Division of Dermatologic Surgery, Mayo Clinic, Rochester, Minnesota, USA.
Arch Dermatol. 2009 Dec;145(12):1391-6. doi: 10.1001/archdermatol.2009.276.
To examine the incidence, tumor burden, and risk factors for nonmelanoma and other skin cancer types in this heart transplant cohort.
Retrospective review of patient medical records.
Tertiary care center. Patients All heart transplant recipients at Mayo Clinic from 1988 to 2006.
Cumulative incidence of skin cancer and tumor burden, with Cox proportional hazards regression models used to evaluate risk factors for posttransplant primary and secondary nonmelanoma skin cancer.
In total, 312 heart transplant patients had 1395 new skin cancers in 2097 person-years (mean, 0.43 per year per patient) with a range of 0 to 306 for squamous cell carcinoma (SCC) and 0 to 17 for basal cell carcinoma (BCC). The cumulative incidence rates of any skin cancer were 20.4%, 37.5%, and 46.4% at 5, 10, and 15 years after heart transplant, respectively. Cumulative incidence of SCC after the first BCC was 98.1% within 7 years. Multivariate analysis showed that posttransplant nonskin cancer, increased age, and heart failure etiologic factors other than idiopathic disease were associated with increased risk of SCC. Posttransplant herpes simplex viral infection, increased age, and use of mycophenolate mofetil for immunosuppression were associated with increased risk of BCC.
With prolonged survival, many heart transplant patients have numerous skin cancers. Vigilant sun protection practices, skin cancer education, and regular skin examination are appropriate interventions in these high-risk patients.
研究该心脏移植队列中非黑色素瘤及其他皮肤癌类型的发病率、肿瘤负荷和危险因素。
对患者病历进行回顾性研究。
三级医疗中心。患者为1988年至2006年在梅奥诊所接受心脏移植的所有患者。
皮肤癌的累积发病率和肿瘤负荷,采用Cox比例风险回归模型评估移植后原发性和继发性非黑色素瘤皮肤癌的危险因素。
在2097人年中,共有312例心脏移植患者发生了1395例新发皮肤癌(平均每位患者每年0.43例),其中鳞状细胞癌(SCC)的范围为0至306例,基底细胞癌(BCC)为0至17例。心脏移植后5年、10年和15年时,任何皮肤癌的累积发病率分别为20.4%、37.5%和46.4%。首次发生BCC后7年内,SCC的累积发病率为98.1%。多因素分析显示,移植后非皮肤癌、年龄增加以及除特发性疾病外的心力衰竭病因与SCC风险增加相关。移植后单纯疱疹病毒感染、年龄增加以及使用霉酚酸酯进行免疫抑制与BCC风险增加相关。
随着生存期延长,许多心脏移植患者会发生多种皮肤癌。对这些高危患者采取警惕的防晒措施、皮肤癌教育和定期皮肤检查是合适的干预措施。